MANGOCEUTICALS, INC.
For the period ended Mar 31, 2026. Filed May 19, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 19, 2026
MGRX$0.19-4.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Loss
| For The Three Months | For The Three Months | |
|---|---|---|
| Ended | Ended | |
| March 31, 2026 | March 31, 2025 | |
| (Unaudited) | (Unaudited) | |
| Net loss | $(3,403,141) | $(4,839,489) |
| Other comprehensive income (loss) | ||
| Foreign currency translation adjustments | (3,193) | 7,624 |
| Comprehensive loss | (3,406,334) | (4,831,865) |
| Less comprehensive loss attributed to non-controlling interest | (1,533) | (98) |
| Comprehensive loss attributable to Mangoceuticals, Inc. stockholders | $(3,404,801) | $(4,831,767) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.